Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer

Fig. 3

Disease-free survival (DFS) (a) and overall survival (OS) (b) between upper rectal versus middle/lower rectal cancer patients receiving neoadjuvant chemoradiation therapy: 58 patients had lesions in the upper rectum and 115 patients had lesions in the middle/lower rectum. The 5-year DFS and 5-year OS rates were 84% and 88% for the patients with upper rectal cancer and 77% and 68% for those with middle/lower rectal cancer (P = 0.251 and P = 0.058, respectively)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us